baber/WOPTO huggingface dataset:
Patent CS-197301-B2 (CS)
Title: Method of producing cyclic derivatives of 1,4-benzoxazine and 1,4-benzothiazine
Inventor: MELLONI PIERO
IPC: C07D207/40
Filed: 1976-12-28
Abstract: Cyclic derivatives of 1,4-benzoxazine and 1,4-benzothiazine are disclosd, such as, for instance, 1H,2,3,3a,4-tetrahydro-2-carbamoylmethyl-imidazo[5,1-c][1,4]benzoxazin -1-one and 1H,2,3,3a,4-tetrahydro-2-carbamoylmethyl-8-chloro-imidazo[5,1-c][1,4]b enzoxazin-1-one. These compounds are active on the central nervous system, and function as antidepressant agents.
Patent JP-H0588257-B2 (JP)
IPC: C08G18/10
Filed: 1985-01-10
Abstract: Coating compositions comprising polymeric compounds containing aliphatic isocyanate groups and ketimines of di- and polyamines in a non-reactive solvent cure slowly in the presence of moisture to provide hard, tough, solvent-resistant surface coatings.
Patent JP-2628670-B2 (JP)
IPC: F25B21/02
Filed: 1988-01-18
Granted: 1997-07-09
Abstract: Apparatus for cooling and deep freezing samples of biological material. The cooling zone, containing the closed plastic vessels with the samples, is enclosed between two parallel, plate-like layered cooling elements. The latter are made of at least two cooling layers containing blocks of Peltier elements, alternating with plates of a heat-conducting metal, preferably aluminium. The disposition with several layers of Peltier elements increases the temperature difference between the inner space and environment. The innermost layer of the cooling elements is a metal plate as well; the outermost layer is a metal plate with means for external cooling, such as channels for circulating water or cooling ribs. The cooling zone is either a metal block with cavities to receive the sample vessels or simply the free space between the two innermost plates of the cooling elements, into which the vessels can be inserted. In one special design the metal block is an exchangeable module or cassette to be inserted into the cooling space. All parts, except the plates cooled externally, are thermally insulated; the cooling space is sealed against humidity by an insulated lid. The apparatus is controlled by a programmable electronic unit, by which a temperature program for the freezing process can be followed. The signals are given by temperature sensors in the cooling zone. In a preferred design, the freezing apparatus, the electronic control unit and the power supply are combined together in portable housing box.
Patent AU-751225-B2 (AU)
Title: Device for positioning surgical instruments
Inventor: ANDRE JACQUES
IPC: A61B90/50
Filed: 1998-11-16
Granted: 2002-08-08
Abstract: The mechanism consists of two articulated elements (4, 5) which rotate about transverse axes (H1, H2) and a deformable element (6) which provides rotation about an axis (C). A surgical instrument (9) is held by a gripping member (7) attached to the deformable element (6). A keyboard, computer and servomechanisms are used to control the mechanism which may slide along a rail (2).
Patent AU-563196-B2 (AU)
Title: Peptide prodrug transport system
Inventor: GILVARG CHARLES
IPC: C07K7/04
Filed: 1983-04-22
Granted: 1987-07-02
Abstract: Prodrugs are described whose structures have a oligopeptide chain which is substituted by a nucleophilic chemotherapeutic residue at the  alpha -position. The products have increased cell membrane permeability and beneficial physico-chemical properties.
Patent AU-718737-B2 (AU)
Title: Method and apparatus for forming fused silica by combustion of liquid reactants
Inventor: HAWTOF DANIEL W
IPC: C03B37/014
Filed: 1996-12-12
Granted: 2000-04-20
Abstract: The present invention is directed to a method for making fused silica glass. A liquid, preferably halide-free, silicon-containing compound capable of being converted by thermal oxidative decomposition to SiO2 is provided and introduced directly into the flame of a combustion burner, thereby forming finely divided amorphous soot. The amorphous soot is deposited on a receptor surface where, either substantially simultaneously with or subsequently to its deposition, the soot is consolidated into a body of fused silica glass. The invention further relates to an apparatus for forming fused silica from liquid, preferably halide-free, silicon-containing reactants which includes: a combustion burner which, in operation, generates a flame; an injector for supplying a liquid silicon-containing compound to the flame to convert the compound by thermal oxidative decomposition to a finely divided amorphous soot; and a receptor surface on which the soot is deposited.
Patent AU-745616-B2 (AU)
Title: Production of substantially monodisperse phosphor particles
Inventor: SANJURJO ANGEL
IPC: C09K11/08
Filed: 1998-12-04
Granted: 2002-03-28
Abstract: This invention relates to a method for producing activated, substantially monodisperse, phosphorescent particles and particles formed thereby. The method suspends substantially monodisperse, phosphor-precursor particles in a fluidizing gas and then introduces a reactive gas to contact the suspended phosphor-precursor particles. Heating the suspended phosphor-precursor particles to a reaction temperature then forms unactivated phosphorescent particles. In another embodiment, the phosphor-precursor particles may be heated to a reaction temperature where they decompose to form the unactivated phosphor particles. The unactivated phosphorescent particles suspended within the fluidizing gas are activated by heating the unactivated phosphorescent particles to an activation temperature forming activated, substantially monodisperse, phosphorescent particles.
Patent AU-560809-B2 (AU)
Title: Xanthine derivatives
Inventor: REGNIER GILBERT
IPC: C07D473/08
Filed: 1983-07-27
Granted: 1987-04-16
Abstract: New xanthine compounds of the formula:   <IMAGE>   in which: R1 is hydrogen or alkyl from C1 to C5 inclusive; R2 is a hydrocarbon radical up to C6 having optionally a double bond, phenyl or benzyl; R3 is hydrogen, alkyl, hydroxyalkyl or dihydroxyalkyl each from C1 to C5 R4 represents:   <IMAGE>   in which: Y is hydrogen, halogen, alkyl or alkoxy from C1 to C5 or hydroxyl; Z is methylene or a straight or branched hydrocarbon radical from C2 to C5 optionally substituted by hydroxyl; and A is an amino group of the formula:   <IMAGE>   p being 2 or 3;   <IMAGE>   in which q is 1 or 2, and X is a single bond, oxygen or   <IMAGE>   in which R5 is hydrogen, alkyl or alkylene up to C5, or   <IMAGE>   in which m is an integer from 2 to 6 and R6 is alkyl from C1 to C5. These new compounds and physiologically tolerable acid addition salts thereof may be used as medicines especially in the treatment of all diseases where it is necessary to inhibit the antigenic antibody reactions.
Patent AU-711208-B2 (AU)
Title: Process for the preparation of chocolate and similar products
Inventor: DUCRET PIERRE
IPC: A23G1/00
Filed: 1997-04-10
Granted: 1999-10-07
Abstract: A new method (I) for the preparation of chocolate and analogous products (II) comprises placing (II) and a water containing composition (III) in an extruder (IV), mixing at a controlled temperature and passing the mixture through a nozzle, so that the resulting product (V) is at a temperature of 0-28 degrees C.
Patent AU-741112-B2 (AU)
Title: Slag crusher
Inventor: GRUHLKE WOLFRAM
IPC: B02C18/14
Filed: 1998-11-26
Granted: 2001-11-22
Abstract: Slag crusher having a shaft extending through a pressure housing which shaft is provided with inlet baffle plates in a funnel-shaped arrangement, stationary cutting knives and cutting knives rotating on the shaft. The shaft is offset with respect to the vertical center line of the pressure housing, so that the crushing area is concentrated in the middle of the slag crusher. The rotating cutting knives are angularly offset on the periphery of the shaft, so that only one rotating knife and two stationary knives are in engagement at a time.
Patent AU-683411-B2 (AU)
Title: Oral-administration forms of a medicament containing pantoprazol
Inventor: DIETRICH RANGO
IPC: A61K9/54
Filed: 1992-06-13
Granted: 1997-11-13
Abstract: The invention relates to compositions for oral administration containing pantoprazole which consist of a core, of an intermediate layer and of an enteric outer layer.
Patent AU-672361-B2 (AU)
Title: Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
Inventor: ELLIS MARTIN KEITH
IPC: A61P43/00
Filed: 1992-06-18
Granted: 1996-10-03
Abstract: The invention concerns novel pharmaceutical compositions containing as an active ingredient a 2-benzoyl-1,3-cyclohexanedione which is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). The compositions are valuable in the treating those disorders and diseases in which it is desirable to intervene in the metabolic sequences catalysed by HPPD, such as in treating tyrosinemia type I.
Patent AU-722077-B2 (AU)
Title: Human antibodies that bind human TNFalpha
Inventor: SALFELD JOCHEN G
IPC: A61P25/00
Filed: 1997-02-10
Granted: 2000-07-20
Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor α (hTNFα) are disclosed. These antibodies have high affinity for hTNFα (e.g., Kd=10−8 M or less), a slow off rate for hTNFα dissociation (e.g., Koff=10−3 sec−1 or less) and neutralize hTNFα activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNFα and for inhibiting hTNFα activity, e.g., in a human subject suffering from a disorder in which hTNFα activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.
Patent AU-605352-B2 (AU)
Title: Process for preparing di-n-propylacetonitrile
Inventor: BOUISSET MICHEL
IPC: B01J23/02
Filed: 1988-09-08
Granted: 1991-01-10
Abstract: Preparation of di-N-propylacetonitrile by a process consisting in heating N-1-propyl-N-butylformamide to a temperature of between 350 DEG C and 550 DEG C and in the absence of oxygen, in the presence of a catalyst consisting of a silica impregnated with 0.1 to 10% by weight of alkali metal cations.
Patent AU-659485-B2 (AU)
Title: Imidazo-fused iso- and heterocycles, process for their preparation, compositions containing them and their use
Inventor: HEITSCH HOLGER
IPC: C07D235/22
Filed: 1992-09-11
Granted: 1995-05-18
Abstract: Compounds of the formula (I) <IMAGE>  in which the symbols have the following meaning:     X represents a monocyclic radical having 3, 4 or 5 ring atoms, R<1>, R<2>, R<3>, R<4>, R<5>, R<12> and R<13> is, for example, an alkyl radical   q is zero or 1   L is, for example, the methylene group   A is the radical, for example, of a heterocycle are highly effective as antagonists of angiotensin II receptors. They can be used as pharmaceuticals or diagnostics.
Patent AU-701570-B2 (AU)
Title: Method and apparatus for spraying grout onto the interior surface of a manhole
Inventor: SHOOK WILLIAM E
IPC: E03F5/02
Filed: 1995-05-01
Granted: 1999-02-04
Abstract: A sprayer (22) for applying an uncured grout to the interior surface of an enclosed wall (10) includes a sprayer motor (30) having a rotor (62) rotatably mounted within the motor housing (40). A spray head (32) is attached to the rotor (62) and a spray conduit (86) is adapted to introduce fluid grout under pressure to the spray head (32) so that it will be thrown radially outwardly in a circular pattern. The motor (30) and spray head (32) are inserted into a conduit (10) and actuated to throw the grout outwardly onto the interior walls of the elongated conduit (10).
Patent AU-762685-B2 (AU)
Title: Multiple access method and system
Inventor: SHATTIL STEVEN J
IPC: H04B1/7115
Filed: 1999-02-10
Granted: 2003-07-03
Abstract: Carrier Interferometry (CI) provides wideband transmission protocols with frequency-band selectivity to improve interference rejection, reduce multipath fading, and enable operation across non-continuous frequency bands. Direct-sequence protocols, such as DS-CDMA, are provided with CI to greatly improve performance and reduce transceiver complexity. CI introduces families of orthogonal polyphase codes that can be used for channel coding, spreading, and/or multiple access. Unlike conventional DS-CDMA, CI coding is not necessary for energy spreading because a set of CI carriers has an inherently wide aggregate bandwidth. Instead, CI codes are used for channelization, energy smoothing in the frequency domain, and interference suppression. CI-based ultra-wideband protocols are implemented via frequency-domain processing to reduce synchronization problems, transceiver complexity, and poor multipath performance of conventional ultra-wideband systems. CI allows wideband protocols to be implemented with space-frequency processing and other array-processing techniques to provide either or both diversity combining and sub-space processing. CI also enables spatial processing without antenna arrays. Even the bandwidth efficiency of multicarrier protocols is greatly enhanced with CI. CI-based wavelets avoid time and frequency resolution trade-offs associated with conventional wavelet processing. CI-based Fourier transforms eliminate all multiplications, which greatly simplifies multi-frequency processing. The quantum-wave principles of CI improve all types of baseband and radio processing.
Patent AU-701490-B2 (AU)
Title: Liquid level sensor for ink jet printers
Inventor: STAMER MICHAEL ELMER
IPC: G01F23/22
Filed: 1995-09-14
Granted: 1999-01-28
Abstract: The ink level sensor of the invention comprises an ink container having a generally cylindrical shield extending downward from its top to define shielded and unshielded compartments within the container. Ink, but not foam, froth or mist, flows under the shield to the shielded compartment. A plurality of conductive rods of differing length extend downwardly into the shielded compartment from the container top. The rods are connected to an impedance network which provides signals representative of the ink level inside the container. A vacuum source can be connected to each compartment to maintain pressure equilibrium in the compartments and to prevent foam, froth or mist from entering the shielded compartment. Alternatively, a return pump is used to force ink into the container such that each compartment can be vented to the atmosphere.
Patent AU-761567-B2 (AU)
Title: Replicative virus driven by the promoter for telomerase reverse transcriptase for use in treating cancer
Inventor: MORIN GREGG B
IPC: A61K35/76
Filed: 2000-02-04
Granted: 2003-06-05
Abstract: Telomerase reverse transcriptase is part of the telomerase complex responsible for maintaining telomere length and increasing the replicative capacity of progenitor cells. Telomerase activity is turned off in mature differentiated cells, but is turned back on again in hyperplastic diseases, including many cancers. This disclosure provides regulatory elements that promote transcription in cells that express telomerase reverse transcriptase (TERT). Oncolytic viruses are described, in which a toxin or a genetic element essential for viral replication is placed under control of the TERT promoter. As a result, the virus replicates preferentially in cells expressing TERT, and selectively lyse cancer cells. The viral constructs of this invention hold considerable promise for the treatment of previously intractable malignancies.
Patent AU-703213-B2 (AU)
Title: Tablet dispenser
Inventor: FLEWITT HARRY
IPC: A61J7/00
Filed: 1995-11-15
Granted: 1999-03-18
Abstract: PCT No. PCT/EP95/04514 Sec. 371 Date Oct. 22, 1997 Sec. 102(e) Date Oct. 22, 1997 PCT Filed Nov. 15, 1995 PCT Pub. No. WO96/15959 PCT Pub. Date May 30, 1996A container for dispensing tablets in which the dispensing opening and/or a dispensing passage upstream of the dispensing opening is constricted such that a tablet is releasably retained with part of the tablet projecting outside of the dispensing opening. The part of the rim of the dispensing opening or an adjacent part of the container is movable relative to the rest of the container so as to facilitate the release of the retained tablet from the container.
Patent AU-615335-B2 (AU)
Title: A method and an arrangement for the manufacture of a laminated material strip
Inventor: CARLSSON LARS
IPC: B26D7/01
Filed: 1989-09-13
Granted: 1991-09-26
Abstract: A method and an arrangement for the manufacture of a laminated material strip which comprises a foil (4) of gas barrier material, e.g. aluminium foil, enclosed in a liquid-tight manner between two external films (2,3). In accordance with the invention a first film (2) is provided with transverse irregularities (9), e.g. folds or elevations, whereafter the foil (4) and the film are sealed to one another. After transverse cutting of the foil (4) at the irregularities (9) the film (2) is stretched and a second film is applied over the foil (4). The method is carried out with the help of an arrangement which comprises co-operating pairs of rolls (5,6; 12,14; 16) for forming the irregularities and cutting and stretching of the film, together with conventional arrangements for heating and laminating.
Patent AU-730628-B2 (AU)
Title: Press belt and press roll cover for papermaking
Inventor: DAVENPORT FRANCIS L
IPC: D21F3/08
Filed: 1999-08-03
Granted: 2001-03-08
Abstract: In a papermaking machine for making paper and paperboard products, a press belt, press roll cover, or long nip shoe press belt, is disclosed that has both a permanent microscale roughness and areas of both hydrophilic and hydrophobic nature which properties promote good sheet smoothness and printability, while allowing for excellent sheet release. <IMAGE>
Patent AU-633519-B2 (AU)
Title: Device for joining accessories to formwork panels
IPC: E04G17/04
Filed: 1989-10-23
Granted: 1993-02-04
Abstract: PCT No. PCT/DE89/00675 Sec. 371 Date May 13, 1991 Sec. 102(e) Date May 13, 1991 PCT Filed Oct. 23, 1989 PCT Pub. No. WO90/05226 PCT Pub. Date May 17, 1990.A device (1) serves for connecting accessory parts (2) to formwork panels, compensating members or suchlike formwork members having stiffening webs or stiffening profiles (3) on their side averted form the forming surface. The device (1) has an essentially U-shaped cross section, the U-arms (4) having fastening locations (5), preferably bores, for the accessory parts (2) such as booms, adjustable props, platform brackets or the like, and in the position of use the U-crosspiece (6) butting and being drawn fast against a stiffening profile (3) and above all against a cross web (3b) provided on this profile (3). At least one of the U-arms (4), preferably both U-arms (4), has an extension (7) passing over part of its length and beyond the U-crosspiece (6) on that side of the U-arms which faces the forming surface in the position of use, the extension being provided as protection against torsion and being adapted to be placed against the longitudinal side face (3a) of the stiffening profile ( 3) and against the transition from the rearward web (3b) to the longitudinal side face (3a). The U-crosspiece (6) of the device (1) has at least one recess or hole (8)-possibly even one open at the edge-for a fastening member to engage, preferably for the shank (9a) of a fastening member (9) to pass through. It is thereby possible for the device (1) to be anchored-in a torsion-proof position and in two orientations rotationally staggered through 90 DEG -to a stiffening profile (3), so that the forces and moments encountered can be transferred well (FIG. 1).
Patent AU-664642-B2 (AU)
Title: Nutrient or medicinal compositions for administration to ruminants
Inventor: HOMME CHRISTIAN PRUD
IPC: A23K1/00
Filed: 1993-09-15
Granted: 1995-11-23
Abstract: The present invention relates to nutrient or drug compositions for administration to ruminants containing one or more biologically-active substances coated with a composition based on fat and chitosan salt.
Patent AU-685396-B2 (AU)
Title: Elimination of false negatives in nucleic acid detection
Inventor: KIEVITS TIM
IPC: C12Q1/6865
Filed: 1993-08-20
Granted: 1998-01-22
Abstract: PCT No. PCT/EP93/02248 Sec. 371 Date Feb. 24, 1995 Sec. 102(e) Date Feb. 24, 1995 PCT Filed Aug. 20, 1993 PCT Pub. No. WO94/04706 PCT Pub. Date Mar. 3, 1994The present invention relates to a method for the elimination of false negative test results in assays for the detection of amplified analyte nucleic acid in a sample. Prior to amplification, an internal control is added to the sample, comprising a nucleic acid distinguishable from the analyte nucleic acid, that can be amplified with the same amplification reagents as the analyte nucleic acid. Preferably the internal control comprises a nucleic acid sequence corresponding to the analyte nucleic acid that has been mutated to discriminate it from the analyte nucleic acid.
Patent AU-649585-B2 (AU)
Title: Attenuated viruses
Inventor: ALMOND JEFFREY WILLIAM
IPC: A61K39/13
Filed: 1990-01-18
Granted: 1994-05-26
Abstract: An attenuated enterovirus or rhinovirus, suitable for use as a vaccine, has an attenuating mutation at least at a position which is, or corresponds with, position 471 or 484 of the genome of poliovirus type 3 Leon strain.
Patent AU-580352-B2 (AU)
Title: Preparation of linear, basic polymer powders
Inventor: BRUNNMUELLER FRITZ
IPC: C08F8/00
Filed: 1985-11-28
Granted: 1989-01-12
Abstract: Linear, basic polymer powders which contain units of the formula <IMAGE>  (I)  and have a Fikentscher K value of from 10 to 200 are prepared by eliminating the formyl groups from N-vinylformamide polymer powders with a gaseous hydrogen halide in the presence of not more than 5% by weight, based on the polymer used, of water.
Patent AU-668598-B2 (AU)
Title: Cuvette matrix
Inventor: JARVIMAKI KARI
IPC: B01L3/00
Filed: 1993-11-09
Granted: 1996-05-09
Abstract: A cuvette matrix has at least one row of connected cuvettes (2) from which at least one is detachable. On the outer surface of the detachable cuvette is a holder (10) to facilitate the cuvette adhering to the sides of an opening in a stand. The holder is at an angle, pref. 45 deg. to the longitudinal axis of the row. Pref. the holder is two plane members on opposite sides of the cuvette.
Patent AU-576926-B2 (AU)
Title: Tetrazole derivatives
Inventor: BAKER STEPHEN RICHARD
IPC: C07D257/04
Filed: 1985-12-17
Granted: 1988-09-08
Abstract: There are described pharmaceutical compounds of the formula <CHEM> in which R<1> is C7-20 alkyl or C7-20 alkenyl containing 1 to 3 double bonds, R<2> and R<3> are each hydrogen or a protecting group, and X is C1-6 alkylene; and salts thereof.
Patent AU-625796-B2 (AU)
Title: Hardenable, fluorinated copolymer, process for its manufacture and its application in varnishes and paints
Inventor: KAPPLER PATRICK
IPC: C08F14/24
Filed: 1990-04-27
Granted: 1992-07-16
Abstract: Curable copolymer containing residues of copolymerisation of a fluoro monomer and of a hydroxylated and/or epoxidised allyl ether, characterised in that:
 a) the fluoro monomer residues originate from the combination of vinylidene fluoride and of another fluoro monomer chosen from tetrafluoroethylene, chlorotrifluoroethylene and hexafluoropropene or of a mixture of at least two of these three monomers
 b) the allyl ether residues originate from one of the compounds of formula: 
<IMAGE>
 with "p" a number chosen from 0 to 3
 and X being (CH2)q-O with "q" a number chosen from 1 to 3
 R5 and R6, identical or different, being chosen from H, CH2OH, CH2-CH2-OH and CH3
 R3 and R4, identical or different, being H or OH
 and "n" and "m", identical or different, being numbers chosen from 0 to 2. 
<??>This curable copolymer is obtained by copolymerisation in solution in an organic solvent. In solution in a suitable solvent, this copolymer is employed in paints and varnishes.